Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)

[1]  C. Zimmer,et al.  Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma , 2017, PloS one.

[2]  G. Reifenberger,et al.  European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.

[3]  R. Magge,et al.  Repeat surgery for recurrent low-grade gliomas should be standard of care , 2016, Clinical Neurology and Neurosurgery.

[4]  M. Weller,et al.  Therapeutic options in recurrent glioblastoma--An update. , 2016, Critical reviews in oncology/hematology.

[5]  F. Escorcia,et al.  External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma , 2016, Expert review of anticancer therapy.

[6]  G. Reifenberger,et al.  Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. , 2015, Neuro-oncology.

[7]  V. Esposito,et al.  Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas , 2015, Journal of Neuro-Oncology.

[8]  M. Berger,et al.  Reoperation for recurrent high-grade glioma: a current perspective of the literature. , 2014, Neurosurgery.

[9]  J. Pichler,et al.  A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma , 2014, Clinical Cancer Research.

[10]  J. Kirkpatrick,et al.  Recurrent malignant gliomas. , 2014, Seminars in radiation oncology.

[11]  D. Brat,et al.  The role of neuropathology in the management of progressive glioblastoma , 2014, Journal of Neuro-Oncology.

[12]  J. Olson,et al.  The role of radiotherapy in the management of progressive glioblastoma , 2014, Journal of Neuro-Oncology.

[13]  J. Tonn,et al.  Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option , 2014, Journal of Neuro-Oncology.

[14]  Ameer L. Elaimy,et al.  Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma. , 2013, World neurosurgery.

[15]  E. Shaw,et al.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Winand N M Dinjens,et al.  Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Debus,et al.  Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma , 2013, Acta oncologica.

[18]  R. Stupp,et al.  New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. , 2012, European journal of cancer.

[19]  C. Willett,et al.  Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. , 2012, International journal of radiation oncology, biology, physics.

[20]  G. Minniti,et al.  Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma , 2011, Journal of Neuro-Oncology.

[21]  Adam P Dicker,et al.  Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Susan M. Chang,et al.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Reifenberger,et al.  NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[25]  E. Fokas,et al.  Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas , 2009, Strahlentherapie und Onkologie.

[26]  E. Shaw,et al.  Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Debus,et al.  Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Debus,et al.  Stereotactic radiosurgery (SRS) , 2005, Cancer.

[29]  J. Debus,et al.  Stereotactically Guided Fractionated Re-irradiation in Recurrent Glioblastoma Multiforme , 2005, Journal of Neuro-Oncology.

[30]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[31]  N. Butowski,et al.  Treatment options for recurrent high-grade gliomas. , 2017, CNS oncology.

[32]  B. Meyer,et al.  Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. , 2016, Neuro-oncology.

[33]  Michael Weller,et al.  Standards of care for treatment of recurrent glioblastoma--are we there yet? , 2013, Neuro-oncology.

[34]  V. Esposito,et al.  Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas , 2012, Journal of Neuro-Oncology.

[35]  J. Tonn,et al.  Irradiation and bevacizumab in high-grade glioma retreatment settings. , 2012, International journal of radiation oncology, biology, physics.

[36]  T. Mikkelsen,et al.  Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival , 2008, Journal of Neuro-Oncology.